2017
DOI: 10.1016/j.ijrobp.2016.10.007
|View full text |Cite
|
Sign up to set email alerts
|

The Red Beam: Past, Present, and Future of Radiation Oncology in Russia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…It was noted that the classification of a centre as academic depends on different criteria in different countries. Whilst most radiotherapy learning (RL) facets vary widely, exposure to plan evaluation is reported as difficult to acquire in most jurisdictions [17][18][19][20][21]. National surveys have demonstrated that perceptions of training fluctuate with time spent in training [22][23][24][25] and this pattern was observed in relation to less common tumour sites and emerging radiation techniques in particular.…”
Section: Variation In Trainingmentioning
confidence: 99%
“…It was noted that the classification of a centre as academic depends on different criteria in different countries. Whilst most radiotherapy learning (RL) facets vary widely, exposure to plan evaluation is reported as difficult to acquire in most jurisdictions [17][18][19][20][21]. National surveys have demonstrated that perceptions of training fluctuate with time spent in training [22][23][24][25] and this pattern was observed in relation to less common tumour sites and emerging radiation techniques in particular.…”
Section: Variation In Trainingmentioning
confidence: 99%
“…To achieve primary radiation oncology specialization, physicians receive additional training that lasts 2.5-4 months but that includes no practical exposure to structure contouring or treatment planning. 19 In 2016, US and Russian academic ROs piloted an in-person, expert-led contouring workshop 20 ; subsequently, 15 contouring workshops covering various disease sites were conducted in Russia with financial support from the Russian Society of Clinical Oncology.…”
mentioning
confidence: 99%